YES1 drives lung cancer growth and progression and predicts sensitivity to dasatinib

Irati Garmendia, María J. Pajares, Francisco Hermida-Prado, Daniel Ajona, Cristina Bértolo, Cristina Sainz, Amaya Lavín, Ana B. Remírez, Karmele Valencia, Haritz Moreno, Irene Ferrer, Carmen Behrens, Myriam Cuadrado, Luis Paz-Ares, Xosé R. Bustelo, Ignacio Gil-Bazo, Daniel Alameda, Fernando Lecanda, Alfonso Calvo, Enriqueta FelipMontse Sánchez-Céspedes, Ignacio I. Wistuba, Rocio Granda-Diaz, Juan Pablo Rodrigo, Juana María García-Pedrero, Ruben Pio, Luis M. Montuenga, Jackeline Agorreta

Research output: Contribution to journal › Article › peer-review

45 Scopus citations

Fingerprint

Dive into the research topics of 'YES1 drives lung cancer growth and progression and predicts sensitivity to dasatinib'. Together they form a unique fingerprint.

Medicine & Life Sciences